Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07550621
What this trial is testing

Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants

Who this might be right for
Healthy Volunteers (HV)
MindRank AI Ltd 28
Post-approval studies (Phase 4)Study completedNCT02147925
What this trial is testing

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Sun Yat-sen University 75
Early research (Phase 1)Not Yet RecruitingNCT07842393
What this trial is testing

IBI3042 in Healthy Adult Participants

Who this might be right for
Healthy Volunteers (HV)
Fortvita Biologics (USA)Inc. 32
Not applicableNot Yet RecruitingNCT07032311
What this trial is testing

Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk

Who this might be right for
Type 2 DiabetesLiver Disease
SIPPA Solutions INC 180
Not applicableNot Yet RecruitingNCT07816744
What this trial is testing

Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression

Who this might be right for
Atrial Fibrillation (AF)Obesity & Overweight
Axel Brandes 480
Not applicableNot Yet RecruitingNCT07818226
What this trial is testing

Effects of GLP-1 Receptor Agonists on Saliva and Oral Health

Who this might be right for
Type 2 DiabetesObesity & OverweightXerostomia+1 more
Kırıkkale University 50
Large-scale testing (Phase 3)Looking for participantsNCT06894784
What this trial is testing

A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

Who this might be right for
Diabetes Type 1
McGill University Health Centre/Research Institute of the McGill University Health Centre 36
Not applicableStudy completedNCT06194955
What this trial is testing

The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function

Who this might be right for
Incretin Effect
University of Copenhagen 50
Early research (Phase 1)Looking for participantsNCT05071898
What this trial is testing

Pharmacogenetics of Response to GLP1R Agonists

Who this might be right for
ObesityDiabetes Type 2
University of Maryland, Baltimore 600
Testing effectiveness (Phase 2)Ended earlyNCT04964388
What this trial is testing

Effect of GLP-1 Receptor Agonists on Trabecular Bone Score

Who this might be right for
Osteoporosis, PostmenopausalDiabetes Mellitus, Type 2
University of Mississippi Medical Center 5
Post-approval studies (Phase 4)Looking for participantsNCT07017270
What this trial is testing

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

Who this might be right for
Kidney Disease, ChronicDiabetesDialysis+1 more
Unity Health Toronto 100
Early research (Phase 1)Study completedNCT05444569
What this trial is testing

LY3537021 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 47
Early research (Phase 1)Study completedNCT01088841
What this trial is testing

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

Who this might be right for
Appetite and General Nutritional DisordersHormone Replacement
University Hospital, Basel, Switzerland 16
Not applicableStudy completedNCT06120556
What this trial is testing

Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

Who this might be right for
Diabetes Mellitus, Type 2
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 130
Not applicableUnknownNCT06344247
What this trial is testing

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Who this might be right for
ObesityChronic Kidney Diseases
RenJi Hospital 48
Early research (Phase 1)Study completedNCT06996886
What this trial is testing

A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formulations

Who this might be right for
Healthy Participants
AstraZeneca 16
Not applicableNot Yet RecruitingNCT07770906
What this trial is testing

Effect of GLP-1 Receptor Agonists on Periodontal Health and Response to Nonsurgical Periodontal Therapy

Who this might be right for
Periodontal DiseaseObesity & Overweight
Cukurova University 40
Early research (Phase 1)Not Yet RecruitingNCT06608329
What this trial is testing

A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects

Who this might be right for
Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830329
What this trial is testing

Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity

Who this might be right for
Hidradenitis Suppurativa
Regeneron Pharmaceuticals 300
Not applicableStudy completedNCT05037045
What this trial is testing

Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
The Affiliated Hospital of Xuzhou Medical University 338
Next Page